Who is sponsoring NCT03816878?

NCT03816878 is sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

What is the status of NCT03816878?

NCT03816878 is currently COMPLETED.

Last reviewed 2025-09-22 · How we verify

Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals

NCT03816878 PHASE1 COMPLETED Results posted

The purpose of this study is to evaluate the immunogenicity and safety of inactivated subunit H5N1 influenza vaccine in individuals who have previously received live attenuated H2N2, H6N1, or H9N2 influenza vaccine, as well as in individuals who have never previously received H5N1 or other pandemic live attenuated influenza vaccines.

Details

Lead sponsor	National Institute of Allergy and Infectious Diseases (NIAID)
Phase	PHASE1
Status	COMPLETED
Enrolment	32
Start date	Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Influenza

Interventions

H5N1 pISV

Countries

United States